Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis

被引:0
|
作者
Assael, Baroukh Maurice [1 ]
机构
[1] Univ Verona, Cyst Fibrosis Ctr, Azienda Osped, I-37100 Verona, Italy
关键词
aerosol; aztreonam; cystic fibrosis; inhaled antibiotics; Pseudomonas aeruginosa; AIRWAY PSEUDOMONAS; SOLUTION AZLI; LYSINE; SAFETY; ANTIBIOTICS; EFFICACY;
D O I
10.1586/ERI.11.131
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An aerosol form of aztreonam lysinate has recently been developed as a treatment for cystic fibrosis patients suffering from chronic Pseudomonas aeruginosa lung colonization. Local administration means the drug can reach mucus concentrations in the order of hundreds of times the MIC(50) of Pseudomonas associated with severe lung disease in cystic fibrosis, resulting in a significant reduction in airway bacterial density and a parallel improvement in lung function. These advantages are maintained over prolonged periods of treatments. Administration of the drug is optimized by the use of a specific eFlow (R) system, resulting in considerable reductions in treatment times when compared with conventional nebulizers. The drug has been proven safe and no concomitant induction of resistance to Pseudomonas was found during the clinical trial period of 18 months. Aztreonam lysinate has been shown to ameliorate pulmonary function in cystic fibrosis patients with chronic airway Pseudomonas infection and this is paralleled by a reduction in bacterial density in the lungs. The increased availability of new aerosolized antibiotics for cystic fibrosis will lead to new scenarios in the treatment of the disease.
引用
收藏
页码:967 / 973
页数:7
相关论文
共 50 条
  • [31] Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study
    Blasi, Francesco
    Carnovale, Vincenzo
    Cimino, Giuseppe
    Lucidi, Vincenzina
    Salvatore, Donatello
    Messore, Barbara
    Bartezaghi, Marta
    Muscianisi, Elisa
    Porpiglia, Pasquale Alberto
    RESPIRATORY MEDICINE, 2018, 138 : 88 - 94
  • [32] Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis
    Somayaji, Ranjani
    Parkins, Michael D.
    THERAPEUTIC DELIVERY, 2015, 6 (02) : 121 - 137
  • [33] Mouse models of chronic lung infection with Pseudomonas aeruginosa:: Models for the study of cystic fibrosis
    Stotland, PK
    Radzioch, D
    Stevenson, MM
    PEDIATRIC PULMONOLOGY, 2000, 30 (05) : 413 - 424
  • [34] Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis
    Evans, Thomas J.
    FUTURE MICROBIOLOGY, 2015, 10 (02) : 231 - 239
  • [35] Novel mouse model of chronic pseudomonas aeruginosa lung infection mimicking cystic fibrosis
    Hoffmann, N
    Rasmussen, TB
    Jensen, PO
    Stub, C
    Hentzer, M
    Molin, S
    Ciofu, O
    Givskov, M
    Johansen, HK
    Hoiby, N
    INFECTION AND IMMUNITY, 2005, 73 (04) : 2504 - 2514
  • [36] Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection
    Coleman, FT
    Mueschenborn, S
    Meluleni, G
    Ray, C
    Carey, VJ
    Vargas, SO
    Cannon, CL
    Ausubel, FM
    Pier, GB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) : 1949 - 1954
  • [37] Metabolic Network Analysis of Pseudomonas aeruginosa during Chronic Cystic Fibrosis Lung Infection
    Oberhardt, Matthew A.
    Goldberg, Joanna B.
    Hogardt, Michael
    Papin, Jason A.
    JOURNAL OF BACTERIOLOGY, 2010, 192 (20) : 5534 - 5548
  • [38] LUNG FUNCTION IMPROVEMENT WITH AZTREONAM FOR INHALATION SOLUTION (AZLI) IN THE SINGLE-ARM EXTENSION OF A RANDOMIZED TRIAL OF INHALED ANTIPSEUDOMONAL ANTIBIOTICS IN PATIENTS WITH CYSTIC FIBROSIS (CF) AND PSEUDOMONAS AERUGINOSA INFECTION
    Assael, B. M.
    Chiron, R.
    Fischer, R.
    Bresnik, M.
    Lewis, S.
    Pressler, T.
    Oermann, C. M.
    PEDIATRIC PULMONOLOGY, 2011, : 312 - 312
  • [39] Successful Eradication of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis
    Singh, J. A.
    Lynch, S.
    Iredell, J.
    Selvadurai, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [40] Pseudomonas aeruginosa and cystic fibrosis:: first colonization to chronic infection
    Laurans, M.
    Arion, A.
    Fines-Guyon, M.
    Regeasse, A.
    Brouard, J.
    Leclercq, R.
    Duhamel, J. F.
    ARCHIVES DE PEDIATRIE, 2006, 13 : S22 - S29